BioNTech
Pharma

BioNTech pays $205M for FDA voucher to speed up cancer pipeline

The BioNTech deal also stands out as most buyers of priority review vouchers keep their identity confidential for competitive reasons.
Angus Liu Nov 11, 2026 8:20am
Asking More of Science How Daiichi Sankyo Is Challenging Assumptions About the Future of Cancer Care

Asking More of Science: How Daiichi Sankyo Is Challenging Assumptions About the Future of Cancer Care

Brought to you by Daiichi Sankyo, Inc.
FDA

FDA hands out 3 API warning letters after record request snubs

Nov 11, 2026 4:20pm
Legend

Legend Biotech drops 16% as soft 2027 outlook tests new CEO

Nov 11, 2026 10:19am
Skyline Shanghai
Favicon Fierce Biotech

Could we see 10 Chinese Big Pharmas within a decade?

Nov 11, 2026 9:00am
Leanne Morgan for Eli Lilly

Lilly taps new Foundayo spokesperson in comedian Leanne Morgan

Nov 10, 2026 6:05pm
More News

Merck KGaA's Pimjetmi wins FDA approval in rare tumor disorder

Nov 10, 2026 5:45pm

ImmunityBio shares tank despite ph. 3 win in first-line NMIBC

Nov 10, 2026 3:06pm

Summit sheds commercial leaders before ivonescimab FDA decision

Nov 10, 2026 2:12pm

J&J's Caplyta scores 2nd ph. 3 win in bipolar mania

Nov 10, 2026 10:01am